The 9th annual Lafora science symposium: a rare epilepsy community makes progress towards clinical readiness
Epilepsy & Behavior · 2025-10 · 171 · 110654
DOI: 10.1016/j.yebeh.2025.110654 ↗Kurz gefasst
Fachartikel in der Zeitschrift Epilepsy & Behavior, 2025-10. Verfasst von Meredith I Williams und 11 weiteren Autor:innen. Beteiligte Einrichtung: Chelsea's Hope Lafora Children Research Fund, 976 Maywick Dr. Lexington, KY 40504, USA; Department of Cellular and Molecular Biology, Baylor College …. Hauptthemen laut MEDLINE: Lafora Disease. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, National Institute of Neurological Disorders and Stroke, National Institutes of Health.
Abstract (Originalsprache)
Lafora disease (LD) is a fatal childhood progressive myoclonus epilepsy and glycogen storage disease that is caused by recessive mutations in either EPM2A or EPM2B. The hallmarks of LD are cytoplasmic, aberrant glycogen-like aggregates, called Lafora bodies (LBs), that drive disease progression. The 9th Annual Lafora Science Symposium was held in San Diego, California and brought together over 70 researchers, clinicians, academic trainees, and friends and family members of patients with LD and 80 attendees joined virtually. This symposium focused primarily on international collaborations for therapeutic development and biomarker identification and strategies for preparing the Lafora community for upcoming clinical trials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Chelsea's Hope Lafora Children Research Fund, 976 Maywick Dr. Lexington, KY 40504, USA; Department of Cellular and Molecular Biology, Baylor College of Medicine, 1 Baylor Plz, Houston, TX 77030 USA.
- Chelsea's Hope Lafora Children Research Fund, 976 Maywick Dr. Lexington, KY 40504, USA.
- Chelsea's Hope Lafora Children Research Fund, 976 Maywick Dr. Lexington, KY 40504, USA; Instituto de Biomedicina de Valencia (CSIC), Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Jaime Roig 1…
- Chelsea's Hope Lafora Children Research Fund, 976 Maywick Dr. Lexington, KY 40504, USA; Elpida Therapeutics, 16501 Ventura Blvd., Suite 400, Encino, CA 91436, USA.
- Chelsea's Hope Lafora Children Research Fund, 976 Maywick Dr. Lexington, KY 40504, USA; Lafora Epilepsy Cure Initiative (LECI), USA; Department of Neurology, Fundación Jiménez Díaz University Hospital and Instituto de I…
- Chelsea's Hope Lafora Children Research Fund, 976 Maywick Dr. Lexington, KY 40504, USA; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB), (Full member of ERN EpiCARE), Padiglione G, Via Altura, 3, 40139 Bolog…
Förderung
- NINDS NIH HHS
- National Institute of Neurological Disorders and Stroke
- National Institutes of Health
Zitieren
APA
Williams, M. I., Donohue, K. J., Sanz, P., Messahel, S., Serratosa, J. M., Duran, J., Michelucci, R., Muccioli, L., Delgado-Escueta, A., Nguyen, V. V., Minassian, B. A., & Gentry, M. S. (2025). The 9th annual Lafora science symposium: a rare epilepsy community makes progress towards clinical readiness. Epilepsy & Behavior, 171, 110654. https://doi.org/10.1016/j.yebeh.2025.110654
Vancouver
Williams MI, Donohue KJ, Sanz P, Messahel S, Serratosa JM, Duran J, et al. The 9th annual Lafora science symposium: a rare epilepsy community makes progress towards clinical readiness. Epilepsy & Behavior. 2025;171:110654. doi:10.1016/j.yebeh.2025.110654
BibTeX
@article{Williams2025,
author = {Williams, Meredith I and Donohue, Katherine J and Sanz, Pascual and Messahel, Souad and Serratosa, Jose M and Duran, Jordi and Michelucci, Roberto and Muccioli, Lorenzo and Delgado-Escueta, Antonio and Nguyen, Viet-Huong V and Minassian, Berge A and Gentry, Matthew S},
title = {The 9th annual Lafora science symposium: a rare epilepsy community makes progress towards clinical readiness},
journal = {Epilepsy & Behavior},
year = {2025},
volume = {171},
pages = {110654},
doi = {10.1016/j.yebeh.2025.110654}
}
EUVIMED